True Myocarditis Uncommon in COVID-19, Review Concludes
A roundup of published autopsy data and a comparison of tissue samples provide some reassurance for clinicians.
A roundup of published autopsy data and a comparison of tissue samples provide some reassurance for clinicians.
The study of VA patients suggests that starting a new BP drug increases the risk of falls and fractures, likely due to hypotension.
Even after the intervention ended, most people kept making progress, but now it’s time to look for an impact on outcomes.
Prevention of stroke gets highlighted by guidelines and is top-of-mind for patients, but heart failure is much more common.
Physicians have adopted a one-size-fits-all approach to direct oral anticoagulants that must be reconsidered, says Geoffrey Barnes.
Edwards Lifesciences says there are “favorable trends” in hard outcomes among patients who have completed 1-year follow-up.
Even after the intervention ended, most people kept making progress, but now it’s time to look for an impact on outcomes.
D2B times are worrisome: just a third of STEMI patients were treated within the guideline-recommended 150 minutes.
Bystander use was zero in at-home OHCAs and < 20% in public, even when an AED was less than a 1-minute walk away.
Though the reasons aren’t clear, drops in estrogen likely play a significant role in accelerating plaque, says Matthew Budoff.
The approval was based on positive data from the TRILUMINATE pivotal trial, which included a highly symptomatic population.